Quarterly Transactions Made in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 786,958 | 583,265 | 1,370,223 | 835,119 | 53,511 | 888,630 | 481,593 | |
| Q4 2021 | 2,529,830 | 7,190,332 | 9,720,162 | 1,952,645 | 423,116 | 2,375,761 | 7,344,401 | |
| Q1 2022 | 1,574,971 | 151,174 | 1,726,145 | 1,717,282 | 141,608 | 1,858,890 | -132,745 | |
| Q2 2022 | 4,505,366 | 2,094,277 | 6,599,643 | 2,856,164 | 720,258 | 3,576,422 | 3,023,221 | |
| Q3 2022 | 8,194,095 | 9,623,655 | 17,817,750 | 4,075,793 | 35,353 | 4,111,146 | 13,706,604 | |
| Q4 2022 | 8,983,735 | 2,396,929 | 11,380,664 | 9,510,605 | 0 | 9,510,605 | 1,870,059 | |
| Q1 2023 | 5,789,012 | 1,062,631 | 6,851,643 | 4,476,907 | 0 | 4,476,907 | 2,374,736 | |
| Q2 2023 | 9,973,119 | 4,884,344 | 14,857,463 | 5,090,145 | 0 | 5,090,145 | 9,767,318 | |
| Q3 2023 | 7,612,236 | 2,321,363 | 9,933,599 | 5,675,145 | 0 | 5,675,145 | 4,258,454 | |
| Q4 2023 | 9,225,677 | 7,751,324 | 16,977,001 | 9,217,641 | 0 | 9,217,641 | 7,759,360 | |
| Q1 2024 | 15,760,418 | 8,360,493 | 24,120,911 | 6,023,345 | 0 | 6,023,345 | 18,097,566 | |
| Q2 2024 | 5,717,583 | 1,656,166 | 7,373,749 | 6,669,957 | 0 | 6,669,957 | 703,792 | |
| Q3 2024 | 4,515,768 | 2,584,398 | 7,100,166 | 4,335,738 | 0 | 4,335,738 | 2,764,428 | |